Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 16, 2025
Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
The lung cancer blame game
The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
Is metastatic prostate cancer tailor-made for precision oncology?
New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients
Crafting a better T cell for immunotherapy
New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy
A chef's offering to her father
Premier Chefs Dinner keynote speaker Suzanne Goin reflects on mentorship, family meals, love and loss
Fred Hutch recruits D. Gary Gilliland as its new president and director
Internationally renowned cancer genetics expert to take the helm in the new year